N/A
Completed N=50
Clinical Evaluation of Two Daily Disposable Contact Lenses
Source: ClinicalTrials.gov NCT01163760 ↗Enrolled (actual)
50
Serious AEs
0.0%
Results posted
Jul 2010
Primary outcomePrimary: Lens Comfort — 3.08; 3.00 units on a scale
Summary
This study seeks to evaluate the clinical performance of two daily disposable contact lenses.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Lens Comfort |
3.08; 3.00 | — |
| SECONDARY Comfort Throughout the Whole Day |
39.2; 36.7 | — |
Eligibility Criteria
Inclusion Criteria
- Be between 21 and 39 years of age.
- Signed Written Informed Consent and Investigator to record this on Case Report Form (CRF) in appropriate space.
- Be existing (i.e. successfully worn for 1-month prior to the study) soft contact lens wearers (no extended wear in the last 3 months, but silicone hydrogels in daily wear are allowed).
- Require a visual correction in both eyes (monovision allowed but no monofit).
- Have a contact lens spherical distance requirement between -1.00D and -6.00D in both eyes.
- Astigmatism of 1.00D or less in both eyes.
- Be able to wear the lens powers available for this study.
- Be correctable to a visual acuity of 20/30 or better in each eye.
- Have normal eyes with no evidence of abnormality or disease. For the purposes of this study a normal eye is defined as one having:
- No amblyopia.
- No evidence of lid abnormality or infection.
- No conjunctival abnormality or infection.
- No clinically significant slit lamp findings (i.e. edema, staining, scarring, vascularisation, infiltrates or abnormal opacities).
- No other active ocular disease.
Exclusion Criteria
- Requires concurrent ocular medication.
- Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear.
- Clinically significant (Grade 3 or 4) corneal edema, corneal vascularisation, corneal staining, tarsal abnormalities, bulbar injection or any other abnormality of the cornea that would contraindicate contact lens wear.
- Diabetic.
- Infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease (e.g., HIV).
- Extended lens wear in last 3 months.
- PMMA or RGP lens wear in the previous 8 weeks.
- Has had refractive surgery. Has had eye injury/surgery within 8 weeks immediately prior to enrollment for this study.
- Abnormal lacrimal secretions.
- Pre-existing ocular irritation that would preclude contact lens fitting.
- Keratoconus or other corneal irregularity.
- Pregnancy, lactating or planning a pregnancy at the time of enrollment.
- Participation in any concurrent clinical trial or in last 60 days."
Data sourced from ClinicalTrials.gov (NCT01163760). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.